Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Long-Term Investments

Amag Pharmaceuticals Long-Term Investments Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Long-Term Investments from 2010 to 2012.
  • Amag Pharmaceuticals Long-Term Investments for the quarter ending March 03, 2012 was $17m a -44.06% decrease of -8m year over year
  • Amag Pharmaceuticals Long-Term Investments for the last 12 months ending March 03, 2012 was $17m a -44.06% decrease of -8m year over year
  • Amag Pharmaceuticals Annual Long-Term Investments for 2011 was $18m a -91.69% decrease of -16m from 2010
  • Amag Pharmaceuticals Annual Long-Term Investments for 2010 was $34m
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Long-Term Investments Data

03/2012$17m
12/2011$18m
09/2011$22m
06/2011$25m
03/2011$33m
12/2010$34m
09/2010$34m
06/2010$39m
03/2010$48m

Annual AMAG Long-Term Investments Data

2011$18m
2010$34m